Nontuberculous mycobacterial and Nocardia infections mimicking pulmonary tuberculosis: a retrospective study of a general hospital patient population in China

References

1. World Health Oragnization Global Tuberculosis Report 2017 Geneva, Switherland: World Health organization; 2017; 43
   [Google Scholar]
2. Wang L, Zhang H, Ruan Y, Chin DP, Xia Y et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014; 383:2057–2064 [View Article][PubMed]
   [Google Scholar]
3. Wang L, Liu X, Huang F, Hennig C, Uplekar M et al. Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice. Bull World Health Organ 2010; 88:937–942 [View Article][PubMed]
   [Google Scholar]
4. Wang L, Cheng S, Xu M, Huang F, Xu W et al. Model collaboration between hospitals and public health system to improve tuberculosis control in China. Int J Tuberc Lung Dis 2009; 13:1486–1492[PubMed]
   [Google Scholar]
5. Wei X, Zou G, Walley J, Yin J, Lonnroth K et al. China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One 2014; 9:e90596 [View Article][PubMed]
   [Google Scholar]
6. Gopinath K, Singh S. Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?. PLoS Negl Trop Dis 2010; 4:e615 [View Article][PubMed]
   [Google Scholar]
7. Hoza AS, Mfinanga SGS, Moser I, König B, Isolation KB. Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?. BMC Infect Dis 2017; 17:407 [View Article][PubMed]
   [Google Scholar]
8. Ministry of Health 2008 Notice about further strengthening of TB report and patient management Beijing: Disease Control Department;
   [Google Scholar]
9. Xia H, Song YY, Zhao B, Kam K-M, O'Brien RJ et al. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis 2013; 17:107–112 [View Article][PubMed]
   [Google Scholar]
10. Tan Y, Li Q, Wang Q, Sun H, Chen J et al. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Sci Rep 2017; 7:3364 [View Article][PubMed]
    [Google Scholar]
11. Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 2016; 54:376–384 [View Article][PubMed]
    [Google Scholar]
12. Raju RM, Raju SM, Zhao Y, Rubin EJ. Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease. Emerg Infect Dis 2016; 22:365–369 [View Article][PubMed]
    [Google Scholar]
13. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182:977–982 [View Article][PubMed]
    [Google Scholar]
14. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013; 42:1604–1613 [View Article][PubMed]
    [Google Scholar]
15. Pang Y, Tan Y, Chen J, Li Y, Zheng H et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J 2017; 49:1601429 [View Article][PubMed]
    [Google Scholar]
16. Wu J, Zhang Y, Li J, Lin S, Wang L et al. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS One 2014; 9:e109736 [View Article][PubMed]
    [Google Scholar]
17. Shao Y, Chen C, Song H, Li G, Liu Q et al. The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China. PLoS Negl Trop Dis 2015; 9:e0003623 [View Article][PubMed]
    [Google Scholar]
18. Yu X, Liu P, Liu G, Zhao L, Hu Y et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect 2016; 73:558–567 [View Article][PubMed]
    [Google Scholar]
19. Wang X, Li H, Jiang G, Zhao L, Ma Y et al. Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008-2011. Emerg Infect Dis 2014; 20:1252–1253 [View Article][PubMed]
    [Google Scholar]
20. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009; 49:e124–e129 [View Article][PubMed]
    [Google Scholar]
21. Ali T, Chakraburtty A, Mahmood S, Bronze MS. Risk of nocardial infections with anti-tumor necrosis factor therapy. Am J Med Sci 2013; 346:166–168 [View Article][PubMed]
    [Google Scholar]
22. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003; 48:3013–3022 [View Article][PubMed]
    [Google Scholar]
23. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009; 15:1556–1561 [View Article][PubMed]
    [Google Scholar]